Cancer Diagnostics Market Size to grow by USD 17744.5 million between 2024-2028
According to a research report “ Cancer Diagnostics Market” by End-user (Hospitals and clinics, Diagnostic laboratories) Type (IVD, Imaging, LDT) Geography (North America, Europe, APAC, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 17744.5 million, at a CAGR of 13.64% during the forecast period. The global cancer diagnostic market is witnessing significant growth due to the rising incidence of cancer caused by unhealthy lifestyle choices, such as poor diet, physical inactivity, tobacco, and alcohol consumption. Additionally, environmental factors, including ionizing radiations, chemical mutagens, infectious micro-organisms, and environmental pollutants, contribute to the disease's prevalence. According to the National Cancer Institute, in the US alone, approximately 1.81 million new cancer cases were diagnosed in 2020, resulting in 606,520 deaths. With an aging population and increasing cancer prevalence, diagnostic costs are projected to escalate. Furthermore, the adoption of expensive, innovative cancer treatments as standards of care will further drive market growth..
Browse market data tables, figures, and in-depth TOC on “Cancer Diagnostics Market” by End-user (Hospitals and clinics, Diagnostic laboratories) Type (IVD, Imaging, LDT) Geography (North America, Europe, APAC, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample
By End-user, the Hospitals and clinics segment is projected to dominate the market size in 2024
The Cancer Diagnostics Market represents a significant business opportunity due to the increasing global burden of cancer and the growing demand for early and accurate diagnosis. Advanced technologies, such as molecular diagnostics and imaging techniques, are driving innovation and improving diagnostic accuracy. Market growth is further fueled by government initiatives and private investments in cancer research and development. Despite challenges, including high costs and regulatory complexities, this market is expected to expand at a robust rate, providing substantial returns for investors and stakeholders.
By Type, IVD segment is expected to hold the largest market size for the year 2024
The Cancer Diagnostics Market represents a significant business opportunity due to the increasing global burden of cancer and the growing demand for early and accurate diagnosis. Advanced technologies, such as molecular diagnostics and imaging techniques, are driving innovation and improving diagnostic accuracy. Market growth is further fueled by government initiatives and partnerships between industry players and research institutions. Overall, the market is poised for robust expansion in the coming years.
North America is forecasted to hold the largest market size by region in 2024
The Cancer Diagnostics Market represents a significant business opportunity due to the rising prevalence of cancer and the increasing demand for early and accurate diagnosis. Advanced technologies, such as molecular diagnostics and imaging techniques, are driving innovation and improving diagnostic accuracy. Market growth is further fueled by government initiatives and partnerships between industry players and research institutions. Despite challenges, including regulatory hurdles and high costs, the market is expected to expand at a robust rate in the coming years.
The Cancer Diagnostics Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:
.
For insights on company offerings- Request a sample report!
Research Analysis Overview
The global Cancer Diagnostics Market is witnessing significant growth due to the increasing incidence of various types of cancer, including Liver, Ovarian, Pancreatic, Kidney, and Skin cancer. MRD (Minimal Residual Disease) testing is a promising technology in cancer diagnostics, which helps in detecting cancer cells that may remain after primary treatment. Companies like Blue Earth Diagnostics and Haystack Oncology are at the forefront of developing innovative MRD testing solutions. Diagnostic testing plays a crucial role in disease progression assessment and treatment decision-making for cancer patients. Laboratory tests, such as proteins and biomarkers, are essential components of cancer diagnostics. The market for cancer diagnostics includes various types of screening, from colon cancer screening to diagnostic imaging procedures in public hospitals and private diagnostic centers and laboratories. The market is driven by the increasing demand for early and accurate cancer diagnosis, the development of new technology, and the growing number of cancer patients. The incidence of cancer, particularly colorectal cancer, is a significant factor fueling market growth. Consumables, such as reagents and assay kits, are an integral part of the cancer diagnostics market. Quest Diagnostics and other key players are investing heavily in research and development to bring new and advanced diagnostic solutions to the market.
Market Research Overview
The global Cancer Diagnostics Market is witnessing significant growth due to the rising incidence of aggressive cancers such as breast, liver, ovarian, pancreatic, kidney, skin, and blood cancers, including cervical, lung, colorectal, and prostate cancers. Companies like Blue Earth Diagnostics, Haystack Oncology, Quest Diagnostics, OverC, Guardant Health, Illumina, and The NCI are at the forefront of developing innovative diagnostic solutions. Mammography, optical imaging, positron emission tomography (PET), magnetic resonance imaging (MRI), SPECT, computed tomography (CT), ultrasound, X-rays, endoscopy, and biopsy are the primary diagnostic tools used for cancer detection. Early detection through screening procedures, public awareness, and mortality rate reduction are key drivers for the market. Risk factors such as diabetes, unhealthy lifestyle, tobacco use, and alcohol use contribute to the increasing incidence of cancer. Genetic tests, treatment, imaging, and treatment outcomes are essential components of cancer diagnosis. Proteins and biomarkers are crucial in identifying cancerous tumors, and laboratory tests play a significant role in diagnostic testing. Technology, consumables, cancer patients, diagnostic laboratories, hospitals, biopsy technique, IVD testing, instruments, and colorectal cancer screening are essential segments of the cancer diagnostics market. GE Healthcare, diagnostic laboratories, public hospitals, private diagnostic centers, and private diagnostic laboratories are major players in the market. Disease progression, diagnostic testing, and treatment outcomes are critical factors influencing market growth.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
